News Novartis less exposed to US pricing pressure, says Jimenez Europe and Asia account for a large share of company's income.
Views & Analysis Recent trends in ANDA litigation Sheila Swaroop and Kaitlin Heinen examine the findings of a recent report.
News Allergan ‘not looking for big deals’ as growth slows Company will put its $27 billion to use, however
News Infex chases after Insmed with bronchiectasis trial win UK biotech Infex is in hot pursuit of Insmed's Brinsupri, the only approved therapy for non-CF bronchiectasis, with its quarterly-dosed antibody.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
